If approved, Hetero Biopharma will be the first company to receive approval for the generic version. “The company will present the data of its trials,” a person in the know told ET. Earlier this month, the Drugs Controller General of India (DCGI) granted emergency use authorisation for the single-dose Sputnik Light vaccine in the country.
